부산대학교 도서관

A. Vogel; M. Pinter; G.E. Villadsen; A. Auriemma; P. Stål; M.E. Reig Monzon; A.M. Matilla Peña; F. Van Bömmel; A. Digklia; M. Gallego Llorente; M. Kothari; C. Schnatwinkel; T. Flieswasser; H. Naqvi; P. Azcue; L. Turner

Annals of Oncology. 36:S79-S80

Julie Jacobs; Vanessa Deschoolmeester; Karen Zwaenepoel; Tal Flieswasser; Christophe Deben; Jolien Van den Bossche; Christophe Hermans; Christian Rolfo; Marc Peeters; Olivier De Wever; Filip Lardon; Vasiliki Siozopoulou; Evelien Smits; Patrick Pauwels

OncoImmunology, Vol 7, Iss 7 (2018)

Ng, H.G.; Anton, P.; Brugger, M.; Churamani, N.; Flieswasser, E.; Hummel, T.; Mayer, J.; Mustafa, W.; Nguyen, T.L.C.; Nguyen, Q.; Soll, M.; Springenberg, S.; Griffiths, S.; Heinrich, S.; Navarro-Guerrero, N.; Strahl, E.; Twiefel, J.; Weber, C.; Wermter, S.

2017 26th IEEE International Symposium on Robot and Human Interactive Communication (RO-MAN) Robot and Human Interactive Communication (RO-MAN), 2017 26th IEEE International Symposium on. :728-731 Aug, 2017

Dewulf, Jonatan; Flieswasser, Tal; Delahaye, Tim; Vangestel, Christel; Miranda, Alan; de Haard, Hans; Jacobs, Julie

EJNMMI Radiopharmacy and Chemistry. December, 2023, Vol. 8 Issue 1

P. Azcue; M.T. Campos Partera; A. Vogel; G. Sapisochin; A. Digklia; G.E. Villadsen; C. Schnatwinkel; M. Kothari; M. Gallego-Llorente; Y.P. Cui; T. Flieswasser; L. Turner; W. Vereecken; A. Moucquot; H. Naqvi; D. Dellamonica

Annals of Oncology. 35:S663

Flieswasser T; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.; Van den Eynde A; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.; Freire Boullosa L; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Melis J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Hermans C; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Merlin C; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Lau HW; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Van Audenaerde J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Lardon F; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Smits E; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium.; Pauwels P; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.; Jacobs J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Argenx BV, Zwijnaarde, Belgium.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

Van den Eynde A; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium. astrid.vandeneynde@uantwerpen.be.; Gehrcken L; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Verhezen T; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Lau HW; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Hermans C; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Lambrechts H; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Flieswasser T; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Quatannens D; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Roex G; Laboratory of Experimental Hematology (LEH), Vaccine and Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Edegem, Belgium.; Zwaenepoel K; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.; Marcq E; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Lab of Dendritic Cell Biology and Cancer Immunotherapy, VIB Center for Inflammation Research, Brussels, Belgium.; Brussels Center for Immunology, Vrije Universiteit Brussel, Brussels, Belgium.; Joye P; Molecular Imaging Center Antwerp (MICA), University of Antwerp, Wilrijk, Belgium.; Cardenas De La Hoz E; Industrial Vision Lab (InViLab), University of Antwerp, Antwerp, Belgium.; Deben C; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Gasparini A; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Iridium Netwerk, Radiation Oncology, Antwerp, Belgium.; Montay-Gruel P; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Iridium Netwerk, Radiation Oncology, Antwerp, Belgium.; Le Compte M; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Lion E; Laboratory of Experimental Hematology (LEH), Vaccine and Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Edegem, Belgium.; Center for Cell Therapy and Regenerative Medicine (CCRG), Antwerp University Hospital, Edegem, Belgium.; Lardon F; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Van Laere S; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.; Siozopoulou V; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; University Hospital Saint-Luc, University of Louvain, Brussels, Belgium.; Campillo-Davo D; Laboratory of Experimental Hematology (LEH), Vaccine and Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Edegem, Belgium.; De Waele J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Pauwels P; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.; Jacobs J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Smits E; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.; Van Audenaerde JRM; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.

Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722 (Electronic) Linking ISSN: 17568722 NLM ISO Abbreviation: J Hematol Oncol Subsets: MEDLINE

Jacobs, J.; Deschoolmeester, V.; Zwaenepoel, K.; Flieswasser, T.; Peeters, M.; Dewever, O.; Lardon, F.; Siozopoulou, V.; Smits, E.; Pauwels, P.

ESMO Open. 3:A348-A348

Flieswasser, T.; Loenhout, J. Van; Zwaenepoel, K.; Rolfo, C.; Lardon, F.; Smits, E.; Jacobs, J.; Pauwels, P.

ESMO Open. 3:A399-A399

Sumanta Kumar Pal; Melissa Andrea Reimers; Benjamin Garmezy; Wenxin Xu; Christopher J. Hoimes; Michael Weinstein; Erika L Cullingford; Anna Ma; Leah M Williams; Henia Dar; Alissa Keegan; Samer Ali Srour

Journal of Clinical Oncology. 42:TPS2676-TPS2676

Freire Boullosa L; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Wilrijk, Belgium.; Van Loenhout J; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Wilrijk, Belgium.; Flieswasser T; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Wilrijk, Belgium.; Hermans C; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Wilrijk, Belgium.; Merlin C; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Wilrijk, Belgium.; Lau HW; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Wilrijk, Belgium.; Marcq E; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Wilrijk, Belgium.; Verschuuren M; Laboratory of Cell Biology and Histology, Antwerp Center for Advanced Microscopy, Department of Veterinary Sciences, University of Antwerp, 2610 Wilrijk, Belgium.; µNEURO Research Centre of Excellence, University of Antwerp, 2610 Wilrijk, Belgium.; De Vos WH; Laboratory of Cell Biology and Histology, Antwerp Center for Advanced Microscopy, Department of Veterinary Sciences, University of Antwerp, 2610 Wilrijk, Belgium.; µNEURO Research Centre of Excellence, University of Antwerp, 2610 Wilrijk, Belgium.; Lardon F; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Wilrijk, Belgium.; Smits ELJ; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Wilrijk, Belgium.; Deben C; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, 2610 Wilrijk, Belgium.

Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101668981 Publication Model: Electronic Cited Medium: Print ISSN: 2076-3921 (Print) Linking ISSN: 20763921 NLM ISO Abbreviation: Antioxidants (Basel) Subsets: PubMed not MEDLINE

Domen A; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610, Wilrijk (Antwerp), Belgium. Andreas.Domen@uantwerpen.be.; Department of Oncology, Antwerp University Hospital (UZA), 2650, Edegem (Antwerp), Belgium. Andreas.Domen@uantwerpen.be.; Deben C; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610, Wilrijk (Antwerp), Belgium.; Verswyvel J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610, Wilrijk (Antwerp), Belgium.; Flieswasser T; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610, Wilrijk (Antwerp), Belgium.; Prenen H; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610, Wilrijk (Antwerp), Belgium.; Department of Oncology, Antwerp University Hospital (UZA), 2650, Edegem (Antwerp), Belgium.; Peeters M; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610, Wilrijk (Antwerp), Belgium.; Department of Oncology, Antwerp University Hospital (UZA), 2650, Edegem (Antwerp), Belgium.; Lardon F; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610, Wilrijk (Antwerp), Belgium.; Wouters A; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, 2610, Wilrijk (Antwerp), Belgium.

Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

Dewulf, Jonatan; Flieswasser, Tal; Delahaye, Tim; Vangestel, Christel; Miranda Menchaca, Alan; de Haard, Hans; Jacobs, Julie; Smits, Evelien; van den Wyngaert, Tim; Elvas, Filipe

EJNMMI Radiopharmacy and Chemistry

Flieswasser T; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium. tal.flieswasser@uantwerpen.be.; Department of Pathology, Antwerp University Hospital, Edegem, Belgium. tal.flieswasser@uantwerpen.be.; Van den Eynde A; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.; Van Audenaerde J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; De Waele J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Lardon F; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Riether C; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; de Haard H; Argenx, Zwijnaarde, Ghent, Belgium.; Smits E; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium.; Pauwels P; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.; Jacobs J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), Wilrijk, Belgium.; Argenx, Zwijnaarde, Ghent, Belgium.

Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE

Freire Boullosa L; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium. Electronic address: laurie.freireboullosa@uantwerpen.be.; Van Loenhout J; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.; Flieswasser T; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.; De Waele J; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.; Hermans C; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.; Lambrechts H; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.; Cuypers B; Adrem Data Lab, Department of Computer Science, University of Antwerp, Antwerp, Belgium; Molecular Parasitology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.; Laukens K; Adrem Data Lab, Department of Computer Science, University of Antwerp, Antwerp, Belgium.; Bartholomeus E; Department of Medical Genetics, University of Antwerp, Antwerp University Hospital, Edegem, Belgium.; Siozopoulou V; Department of Pathology, Antwerp University Hospital, Edegem, Belgium.; De Vos WH; Laboratory of Cell Biology and Histology, Department of Veterinary Sciences, University of Antwerp, Wilrijk, Belgium.; Peeters M; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium; Department of Oncology, Multidisciplinary Oncological Center Antwerp, Antwerp University Hospital, Edegem, Belgium.; Smits ELJ; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Edegem, Belgium.; Deben C; Center for Oncological Research (CORE), Integrated Personalized & Precision Oncology Network (IPPON), University of Antwerp, Wilrijk, Belgium.

Publisher: Elsevier, B.V Country of Publication: Netherlands NLM ID: 101605639 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2317 (Electronic) Linking ISSN: 22132317 NLM ISO Abbreviation: Redox Biol Subsets: MEDLINE

Flieswasser T; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), 2610 Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, 2650 Edegem, Belgium.; Van Loenhout J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), 2610 Wilrijk, Belgium.; Freire Boullosa L; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), 2610 Wilrijk, Belgium.; Van den Eynde A; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), 2610 Wilrijk, Belgium.; De Waele J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), 2610 Wilrijk, Belgium.; Van Audenaerde J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), 2610 Wilrijk, Belgium.; Lardon F; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), 2610 Wilrijk, Belgium.; Smits E; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), 2610 Wilrijk, Belgium.; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, 2650 Edegem, Belgium.; Pauwels P; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), 2610 Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, 2650 Edegem, Belgium.; Jacobs J; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), 2610 Wilrijk, Belgium.; Department of Pathology, Antwerp University Hospital, 2650 Edegem, Belgium.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409 (Electronic) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

Flieswasser T; Center for Oncological Research (CORE), University of Antwerp, 2610 Wilrijk, Belgium. tal.flieswasser@uantwerpen.be.; Department of Pathology, Antwerp University Hospital, 2650 Edegem, Belgium. tal.flieswasser@uantwerpen.be.; Camara-Clayette V; Translational Hematology Unit, AMMICa INSERMUS23/CNRS UMR3655, Gustave Roussy Cancer Campus, 94805 Villejuif, France. valerie.camara-clayette@gustaveroussy.fr.; Danu A; Hematology Department, Gustave Roussy Cancer Campus, 94805 Villejuif, France. Alina.danu@gustaveroussy.fr.; Bosq J; Pathology Laboratory, Gustave Roussy Cancer Campus, 94805 Villejuif, France. jacques.bosq@gustaveroussy.fr.; Ribrag V; Département des Innovations Thérapeutiques et Essais Précoces (DITEP), Université Paris-Saclay, Gustave Roussy Cancer Campus, 94805 Villejuif, France. vincent.ribrag@gustaveroussy.fr.; INSERM U1170, 94805 Villejuif, France. vincent.ribrag@gustaveroussy.fr.; Zabrocki P; Argenx, 9052 Zwijnaarde, Belgium. pzabrocki@argenx.com.; Van Rompaey L; Argenx, 9052 Zwijnaarde, Belgium. lvanrompaey@argenx.com.; de Haard H; Argenx, 9052 Zwijnaarde, Belgium. hdehaard@argenx.com.; Zwaenepoel K; Center for Oncological Research (CORE), University of Antwerp, 2610 Wilrijk, Belgium. karen.zwaenepoel@uza.be.; Department of Pathology, Antwerp University Hospital, 2650 Edegem, Belgium. karen.zwaenepoel@uza.be.; Smits E; Center for Oncological Research (CORE), University of Antwerp, 2610 Wilrijk, Belgium. evelien.smits@uza.be.; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, 2650 Edegem, Belgium. evelien.smits@uza.be.; Pauwels P; Center for Oncological Research (CORE), University of Antwerp, 2610 Wilrijk, Belgium. patrick.pauwels@uza.be.; Department of Pathology, Antwerp University Hospital, 2650 Edegem, Belgium. patrick.pauwels@uza.be.; Jacobs J; Center for Oncological Research (CORE), University of Antwerp, 2610 Wilrijk, Belgium. julie.jacobs@uantwerpen.be.; Department of Pathology, Antwerp University Hospital, 2650 Edegem, Belgium. julie.jacobs@uantwerpen.be.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Van Loenhout J; Center for Oncological Research, University of Antwerp, 2610 Wilrijk, Belgium. jinthe.vanloenhout@uantwerpen.be.; Flieswasser T; Center for Oncological Research, University of Antwerp, 2610 Wilrijk, Belgium. tal.flieswasser@uantwerpen.be.; Freire Boullosa L; Center for Oncological Research, University of Antwerp, 2610 Wilrijk, Belgium. Laurie.freireboullosa@uantwerpen.be.; De Waele J; Center for Oncological Research, University of Antwerp, 2610 Wilrijk, Belgium. jorrit.dewaele@uantwerpen.be.; Van Audenaerde J; Center for Oncological Research, University of Antwerp, 2610 Wilrijk, Belgium. jonas.vanaudenaerde@uantwerpen.be.; Marcq E; Center for Oncological Research, University of Antwerp, 2610 Wilrijk, Belgium. elly.marcq@uantwerpen.be.; Jacobs J; Center for Oncological Research, University of Antwerp, 2610 Wilrijk, Belgium. julie.jacobs@uantwerpen.be.; Lin A; Center for Oncological Research, University of Antwerp, 2610 Wilrijk, Belgium. abraham.lin@uantwerpen.be.; Plasma, Laser Ablation and Surface Modelling Group, University of Antwerp, 2610 Wilrijk, Belgium. abraham.lin@uantwerpen.be.; Lion E; Laboratory of Experimental Hematology, University of Antwerp, 2610 Wilrijk, Belgium. eva.lion@uantwerpen.be.; Dewitte H; Laboratory of General Biochemistry and Physical Pharmacy, Ghent University, 9000 Ghent, Belgium. heleen.dewitte@ugent.be.; Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel, 1090 Jette, Belgium. heleen.dewitte@ugent.be.; Peeters M; Center for Oncological Research, University of Antwerp, 2610 Wilrijk, Belgium. marc.peeters@uza.be.; Department of Oncology, Multidisciplinary Oncological Center Antwerp, Antwerp University Hospital, 2650 Edegem, Belgium. marc.peeters@uza.be.; Dewilde S; Proteinchemistry, proteomics and epigenetic signaling group, University of Antwerp, 2610 Wilrijk, Belgium. sylvia.dewilde@uantwerpen.be.; Lardon F; Center for Oncological Research, University of Antwerp, 2610 Wilrijk, Belgium. filip.lardon@uantwerpen.be.; Bogaerts A; Plasma, Laser Ablation and Surface Modelling Group, University of Antwerp, 2610 Wilrijk, Belgium. annemie.bogaerts@uantwerpen.be.; Deben C; Center for Oncological Research, University of Antwerp, 2610 Wilrijk, Belgium. christophe.deben@uantwerpen.be.; Smits E; Center for Oncological Research, University of Antwerp, 2610 Wilrijk, Belgium. evelien.smits@uza.be.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Van Den Eynde, A.; Van Audenaerde, J.; De Waele, J.; Flieswasser, T.; Gehrcken, L.; Lau, H. W.; Merlin, C.; Roex, G.; Campillo-Davo, D.; Jacobs, J.; Peeters, M.; Lardon, F.; Smits, E.; Pauwels, P.

HUMAN GENE THERAPY; APR 2022, 33 7-8, pA21-pA21, 1p.